| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0009 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |